CD56 marks an effector T cell subset in the human intestine

被引:26
|
作者
Cohavy, Offer [1 ]
Targan, Stephan R. [1 ]
机构
[1] Cedars Sinai Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA
来源
JOURNAL OF IMMUNOLOGY | 2007年 / 178卷 / 09期
关键词
D O I
10.4049/jimmunol.178.9.5524
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells are key mediators of intestinal immunity, and specific T cell subsets can have differing immunoregulatory roles in animal models of mucosal inflammation. In this study, we describe human CD56(+) T cells as a morphologically distinct population expressing a mature, nonproliferative phenotype that is frequent in the gut. Enhanced potential for IFN-gamma and TNF synthesis suggested a proinflammatory function, and we directly demonstrate effector function mediated by direct T-T interaction with responder cells in vitro. CD56(+) Ir cells from peripheral blood responded to the gut-related CD2 signal, and were necessary for effective CD2-mediated proliferation of peripheral blood CD56(-) T cells. Our findings associate CD56(+) T cells with the intestinal immune compartment and suggest a putative effector function in human mucosal immunity.
引用
收藏
页码:5524 / 5532
页数:9
相关论文
共 50 条
  • [41] Impact of polysialylated CD56 on natural killer cell cytotoxicity
    Jeannette M Moebius
    Darius Widera
    Juergen Schmitz
    Christian Kaltschmidt
    Christoph Piechaczek
    BMC Immunology, 8
  • [42] CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15
    Van Acker, Heleen H.
    Van Acker, Zoe P.
    Versteven, Maarten
    Ponsaerts, Peter
    Pende, Daniela
    Berneman, Zwi N.
    Anguille, Sebastien
    Van Tendeloo, Viggo F.
    Smits, Evelien L.
    CANCERS, 2019, 11 (07)
  • [43] CD56 and CD10-positive B-cell lymphoma
    Weisberger, J
    Gorczyca, W
    Liu, Z
    Goldstein, M
    Tugulea, S
    LABORATORY INVESTIGATION, 2003, 83 (01) : 258A - 258A
  • [44] Pathological study of plasma cell neoplasms and evaluation of CD56
    Krayem, D.
    VIRCHOWS ARCHIV, 2018, 473 : S182 - S182
  • [45] CD56 and CD10-positive B-cell lymphoma
    Weisberger, J
    Gorczyca, W
    Liu, Z
    Goldstein, M
    Tugulea, S
    MODERN PATHOLOGY, 2003, 16 (01) : 258A - 258A
  • [46] CD56 reactivity in small cell carcinoma of the uterine cervix
    Albores-Saavedra, J
    Latif, S
    Carrick, KS
    Alvarado-Cabrero, I
    Fowler, MR
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (02) : 113 - 117
  • [47] CD56 negative extranodal NK/T cell lymphoma, nasal-type with cytotoxic T-cell phenotype
    Grandinetti, Lisa
    Geskin, Larisa
    Akilov, Oleg
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB117 - AB117
  • [48] Significance of cell adhesion molecules, CD56/NCAM in particular, in human tumor growth and spreading
    Zeromski, J
    Nyczak, E
    Dyszkiewicz, W
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 : 36 - 37
  • [49] A Novel Human Effector B cell Subset
    de Veen, Willem van
    Globlinska, Anna
    Wirz, Oliver F.
    Jan-Sen, Kirstin
    Stanic, Barbara
    Giner, Francesc Castro
    Neumann, Avidan
    Spits, Hergen
    Akdis, Cezmi A.
    Akdis, Muebeccel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB14 - AB14
  • [50] EVIDENCE OF A SELECTIVE DEPLETION OF A CD16(+) CD56(+) CD8(+) NATURAL-KILLER-CELL SUBSET DURING HIV-INFECTION
    LUCIA, B
    JENNINGS, C
    CAUDA, R
    ORTONA, L
    LANDAY, AL
    CYTOMETRY, 1995, 22 (01): : 10 - 15